| Ashok K Patel, MD | |
|
14500 99th Ave N, Maple Grove, MN 55369-4730 | |
| (763) 898-1000 | |
| Not Available |
| Full Name | Ashok K Patel |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 42 Years |
| Location | 14500 99th Ave N, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528001575 | NPI | - | NPPES |
| 169148 | Other | MN | UCARE # |
| 10241 | Other | MN | NDBS # |
| 0402618 | Other | MN | MEDICA # |
| 20249PA | Other | MN | MNBS # |
| MN100016 | Other | MN | LHS/BANNERHEALTH # |
| HP19585 | Other | MN | HEALTHPARTNERS # |
| 13408 | Medicaid | MN | |
| 844575 | Other | MN | AMERICA'S PPO/ARAZ # |
| 628070600 | Medicaid | MN | |
| DA9021015705 | Other | MN | PREFERRED ONE # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 28246 (Minnesota) | Secondary |
| 207R00000X | Internal Medicine | 28246 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Clinics | 7113830142 | 658 |
| Fairview Express Care | 3375645179 | 1523 |
News Archive
Using a pediatric chemotherapy regimen to treat young adults with acute lymphoblastic leukemia (ALL) significantly improved their outcomes compared to what has historically been achieved with 'adult' treatment protocols, report Dana-Farber Cancer Institute scientists.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
Forty percent of female doctors in a new study stopped working or moved to working part time within a few years of finishing their medical training. In contrast, all of the male doctors kept working full time. The findings were published online today in JAMA Network Open.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
› Verified 5 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Using a pediatric chemotherapy regimen to treat young adults with acute lymphoblastic leukemia (ALL) significantly improved their outcomes compared to what has historically been achieved with 'adult' treatment protocols, report Dana-Farber Cancer Institute scientists.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
Forty percent of female doctors in a new study stopped working or moved to working part time within a few years of finishing their medical training. In contrast, all of the male doctors kept working full time. The findings were published online today in JAMA Network Open.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
› Verified 5 days ago
| Entity Name | Fairview Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
Using a pediatric chemotherapy regimen to treat young adults with acute lymphoblastic leukemia (ALL) significantly improved their outcomes compared to what has historically been achieved with 'adult' treatment protocols, report Dana-Farber Cancer Institute scientists.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
Forty percent of female doctors in a new study stopped working or moved to working part time within a few years of finishing their medical training. In contrast, all of the male doctors kept working full time. The findings were published online today in JAMA Network Open.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
› Verified 5 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Using a pediatric chemotherapy regimen to treat young adults with acute lymphoblastic leukemia (ALL) significantly improved their outcomes compared to what has historically been achieved with 'adult' treatment protocols, report Dana-Farber Cancer Institute scientists.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
Forty percent of female doctors in a new study stopped working or moved to working part time within a few years of finishing their medical training. In contrast, all of the male doctors kept working full time. The findings were published online today in JAMA Network Open.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
› Verified 5 days ago
| Entity Name | Sanford Health Network North |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1043218753 PECOS PAC ID: 8022206663 Enrollment ID: O20180222001872 |
News Archive
Using a pediatric chemotherapy regimen to treat young adults with acute lymphoblastic leukemia (ALL) significantly improved their outcomes compared to what has historically been achieved with 'adult' treatment protocols, report Dana-Farber Cancer Institute scientists.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
Forty percent of female doctors in a new study stopped working or moved to working part time within a few years of finishing their medical training. In contrast, all of the male doctors kept working full time. The findings were published online today in JAMA Network Open.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashok K Patel, MD 1720 Highway 59 S, Thief River Falls, MN 56701-4331 Ph: (218) 681-4747 | Ashok K Patel, MD 14500 99th Ave N, Maple Grove, MN 55369-4730 Ph: (763) 898-1000 |
News Archive
Using a pediatric chemotherapy regimen to treat young adults with acute lymphoblastic leukemia (ALL) significantly improved their outcomes compared to what has historically been achieved with 'adult' treatment protocols, report Dana-Farber Cancer Institute scientists.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
Forty percent of female doctors in a new study stopped working or moved to working part time within a few years of finishing their medical training. In contrast, all of the male doctors kept working full time. The findings were published online today in JAMA Network Open.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
› Verified 5 days ago
Dr. Karin Soby Gilkison, M.D./M.P.H. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10150 Niagra Lane N #210, Maple Grove, MN 55369 Phone: 612-871-1145 | |
Katti Lauren Woerner, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14500 99th Ave N, Medical Specialty Clinic, Maple Grove, MN 55369 Phone: 763-898-1000 Fax: 763-898-1323 | |
Asim Said Khan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9825 Hospital Dr Ste 300, Maple Grove, MN 55369 Phone: 763-587-7900 Fax: 763-494-7501 | |
Daniel Keeley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9555 Upland Ln N, Maple Grove, MN 55369 Phone: 952-993-1440 | |
Dr. Viet Pham, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9875 Hospital Dr, Maple Grove, MN 55369 Phone: 763-581-1000 | |
Dr. Kristina R Liaugaudas, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15800 95th Ave N, Maple Grove, MN 55369 Phone: 952-993-1440 | |
Aazim Kamal Omer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14500 99th Ave N, Maple Grove, MN 55369 Phone: 763-898-1000 |